Searches were conducted using combinations of keywords and Medical Subject Headings (MeSH) terms related to incretin-based therapies and obesity, including GLP-1 receptor agonists, dual agonists, triple agonists, liraglutide, semaglutide, tirzepatide, mazdutide, retatrutide, adolescent obesity, and pediatric obesity
This article provides evidence-based guidance on recognising serious symptoms, managing mild discomfort, and knowing when to seek medical advice whilst taking Wegovy
Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (736) amide secretion by intestinal L cell
Frequently Asked Questions What is IGF-1 LR3 studied for in research
Oxidative stress promotes permeability of the blood-brain barrier: implications for the pathogenesis of Alzheimer's disease